IRONWOOD PHARMACEUTICALS INC
Public company- Headquarters
- BOSTON, Massachusetts
- Ticker
- IRWD
- CIK
- 0001446847
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOTammi Gaskins | Oct 16, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive appointment
CEO appointed: Tammi Gaskins
Tammi Gaskins was named Chief Executive Officer of IRONWOOD PHARMACEUTICALS INC, effective January 1, 2027. Tammi Gaskins succeeds Thomas McCourt. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 16, 2026Role: Chief Executive Officer
- Executive departure
CEO departs: Thomas McCourt
Thomas McCourt, Chief Executive Officer of IRONWOOD PHARMACEUTICALS INC, retires the role, effective December 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 16, 2026Role: Chief Executive Officer
Last verified Nov 8, 2026